Hodgkin Lymphoma - Frontline Therapy

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
08:02

ASH 2022 Conference Coverage

ASH 2022 Results From Phase III BMT CTN 1703: Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil as the New Standard for GVHD Prophylaxis in Reduced Intensity Conditioning

FEATURING Shernan Holtan
  • 358 views
  • December 19, 2022
  • 1
04:37

PrecisCa

What Is Nodular Lymphocyte Predominant Hodgkin Lymphoma and How Do You Treat It?

FEATURING Jeremy Abramson
  • 49 views
  • December 15, 2022
  • 1
41:20

SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Hodgkin Lymphoma

FEATURING Nancy Bartlett
  • 351 views
  • December 6, 2022
  • 1
16:18

SOHO 4th Italian Conference

SOHO Italy 2022: How I Manage Hodgkin Lymphoma in the USA

FEATURING Amanda Cashen
  • 125 views
  • November 30, 2022
08:51

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malignancies

FEATURING Supawee Saengboon
  • 142 views
  • October 17, 2022
  • 1
10:35

SOHO 2022 Tenth Annual Meeting

SOHO 2022 Next Questions: Hodgkin Lymphoma

FEATURING Nancy Bartlett
  • 247 views
  • October 14, 2022
16:18

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Treatment of Hodgkin Lymphoma

FEATURING Alison Moskowitz
  • 235 views
  • October 14, 2022
  • 1
11:16

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymphoma

FEATURING Christian Steidl
  • 80 views
  • October 13, 2022
11:27

SOHO 2022 Tenth Annual Meeting

SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma

FEATURING Carlos Ramos
  • 24 views
  • October 13, 2022
42:09

University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

FEATURING Manali Kamdar
  • 859 views
  • September 7, 2022
  • 6
07:10

Total Health

2022 Sedona ASCO Updates on the Frontline Hodgkin Lymphoma: 1L Chemo in ECHELON-1 Trial

FEATURING Bradley Haverkos
  • 32 views
  • September 6, 2022
  • 1
38:32

Indy Hematology Review

State of the Art: Current and Emerging Treatment of Hodgkin’s Lymphoma

FEATURING Ranjana Advani
  • 45 views
  • September 6, 2022
13:48

Anna Sureda

Safety Data of Brentuximab Vedotin in cHL and Management of Adverse Reactions: A Focus on Peripheral Neuropathy

  • 492 views
  • August 30, 2022
  • 1
19:51

UChicago Medicine

Update on Immunotherapy Efforts in cHL and DLBCL

FEATURING Justin Kline
  • 222 views
  • August 19, 2022
  • 1
01:52

EHA 2022 Conference Coverage

Lecture Summary - EHA 2022 Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1

FEATURING John Radford
  • 21 views
  • July 26, 2022
15:23

EHA 2022 Conference Coverage

Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1

FEATURING John Radford
  • 387 views
  • July 26, 2022
  • 1
49

Siddhartha Ganguly

Lecture Summary - Updates in Hodgkin Lymphoma

  • 18 views
  • July 26, 2022
19:13

Siddhartha Ganguly

Updates in Hodgkin Lymphoma

  • 148 views
  • July 26, 2022
11:27

Penn Medicine Abramson Cancer Center

EHA and ASCO 2022 Penn Medicine Updates on Targeted Therapies and Immunotherapies in Lymphoma

FEATURING Stefan Barta
  • 189 views
  • July 15, 2022
19:28

19th Annual International Ultmann Chicago Lymphoma Symposium

Impact of the Immune Landscape on Hodgkin Lymphoma Prognosis and Treatment

FEATURING Christian Steidl
  • 112 views
  • July 11, 2022
  • 1
42:23

19th Annual International Ultmann Chicago Lymphoma Symposium

COVID-19 in Patients With Lymphoma: Treatment Approaches, Vaccination, and Prophylactic Strategies

FEATURING Natasha Pettit
  • 162 views
  • July 11, 2022
20:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Post-Acute Outcomes After HL: An Epidemiologic Perspective

FEATURING Lindsay Morton
  • 65 views
  • July 8, 2022
  • 1
41:39

19th Annual International Ultmann Chicago Lymphoma Symposium

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis, and Treatment

FEATURING Kenneth Cohen
  • 154 views
  • July 8, 2022
01:07

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chemo in Newly Diagnosed, Early Unfavorable, or Advanced cHL

FEATURING Jane Winter
  • 44 views
  • June 24, 2022
09:39

ASCO 2022 Conference Coverage

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chemo in Newly Diagnosed, Early Unfavorable, or Advanced cHL

FEATURING Jane Winter
  • 14 views
  • June 24, 2022

Hodgkin Lymphoma - Frontline Therapy

No subtopics